|
Temps réel estimé
Cboe Europe
17:25:00 01/10/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,8000 SEK | +1,01% |
|
+25,44% | -75,46% |
| 24/09 | Publication d’une étude sur Orviglance d’Ascelia dans une revue scientifique | FW |
| 10/09 | Ascelia Pharma a tenu une réunion avec la FDA concernant Orviglance | FW |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,01% | +25,44% | +28,29% | -72,89% | -75,46% | -76,83% | -79,53% | -97,34% | - | 10,59 M | |
| +4,16% | -0,36% | +8,11% | +34,40% | +84,62% | +49,37% | +94,17% | +9,52% | - | 74,46 Md | |
| -0,61% | +0,81% | -5,03% | +6,05% | +17,41% | +27,25% | +80,21% | +220,61% | +5 462,46% | 60,14 Md | |
| -2,47% | -1,58% | -2,91% | -0,28% | +4,31% | +4,94% | +33,41% | -19,30% | +200,80% | 48,15 Md | |
| -1,79% | -4,23% | +1,95% | +29,62% | +16,84% | +29,24% | +35,85% | +9,04% | +228,40% | 44,25 Md | |
| +2,05% | +4,56% | -0,42% | +11,45% | +162,37% | +355,69% | +698,55% | +617,65% | - | 43,99 Md | |
| -0,82% | +1,00% | +1,37% | +25,05% | +19,67% | +8,48% | +103,69% | +1,93% | +1 072,84% | 41,61 Md | |
| +3,32% | +3,49% | -2,81% | +5,94% | +6,51% | +11,18% | +51,23% | -13,94% | +145,56% | 29,97 Md | |
| +4,77% | +6,16% | +14,76% | +61,99% | +78,28% | +36,77% | +22,78% | -55,69% | - | 29,31 Md | |
| -3,67% | -8,71% | -8,68% | +3,71% | -36,24% | -24,66% | +337,39% | +305,28% | +662,12% | 24,93 Md | |
| -0,55% | -1,15% | -3,75% | +4,47% | +3,07% | -4,00% | -12,98% | -61,49% | - | 24,69 Md | |
| -1,28% | +1,98% | +7,73% | +28,50% | +14,11% | +16,44% | -5,36% | -16,07% | +102,54% | 21,27 Md | |
| -1,84% | -1,24% | +5,09% | +12,75% | +9,12% | +12,69% | +152,68% | +213,29% | +1 907,52% | 17,42 Md | |
| -3,70% | -0,43% | -16,13% | -3,15% | +176,14% | +152,01% | +328,65% | +1 525,59% | +638,60% | 15,8 Md | |
| -0,37% | -3,86% | +4,42% | +9,14% | +19,74% | +18,49% | +42,76% | -29,43% | +81,54% | 14,79 Md | |
| -0,38% | -0,91% | -12,17% | -14,64% | - | - | - | - | - | 14,96 Md | |
| -3,46% | -3,40% | +27,23% | +28,61% | +34,17% | -9,96% | - | - | - | 14,78 Md | |
| +0,33% | +1,62% | +3,52% | +9,14% | +34,36% | +42,94% | +165,03% | +173,40% | +362,97% | 14,47 Md | |
| +2,96% | +0,83% | -2,05% | +11,65% | +24,17% | -5,25% | +535,77% | - | - | 14,83 Md | |
| -0,79% | -0,61% | +3,65% | +27,74% | +46,70% | +71,66% | +51,32% | -29,77% | +249,72% | 14,08 Md | |
| Moyenne | -0,22% | +3,30% | +2,61% | +10,96% | +33,68% | +37,71% | +146,42% | +161,96% | +926,26% | 28,2 Md | |
| Moyenne pondérée par Capi. | +0,23% | +1,84% | +1,21% | +17,34% | +42,77% | +51,37% | +149,39% | +142,24% | +1 352,80% |
- Bourse
- Actions
- Action ACE
- Secteur Ascelia Pharma AB
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
